Effects of bovine colostrum supplementation on immune variables in highly trained cyclists

Cecilia M. Shing, Jonathan Peake, Katsuhiko Suzuki, Mitsuharu Okutsu, Rosie Pereira, Lesley Stevenson, David G. Jenkins, Jeff S. Coombes

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The aim of this study was to investigate the influence of low-dose bovine colostrum protein concentrate (CPC) supplementation on selected immune variables in cyclists. Twenty-nine highly trained male road cyclists completed an initial 40-km time trial (TT40) and were then randomly assigned to either a supplement (n = 14, 10 g bovine CPC/day) or placebo group (n = 15, 10 g whey protein concentrate/day). After 5 wk of supplementation, the cyclists completed a second TT40. They then completed 5 consecutive days of high-intensity training (HIT) that included a TT40, followed by a final TT40 in the following week. Venous blood and saliva samples were collected immediately before and after each TT40, and upper respiratory illness symptoms were recorded over the experimental period. Compared with the placebo group, bovine CPC supplementation significantly increased preexercise serum soluble TNF receptor 1 during the HIT period (bovine CPC = 882 ± 233 pg/ml, placebo = 468 ± 139 pg/ml; P = 0.039). Supplementation also suppressed the postexercise decrease in cytotoxic/suppressor T cells during the HIT period (bovine CPC = -1.0 ± 2.7%, placebo = -9.2 ± 2.8%; P = 0.017) and during the following week (bovine CPC = 1.4 ± 2.9%, placebo = -8.2 ± 2.8%; P = 0.004). Bovine CPC supplementation prevented a postexercise decrease in serum IgG 2 concentration at the end of the HIT period (bovine CPC = 4.8 ± 6.8%, P = 0.88; placebo = -9.7 ± 6.9%, P = 0.013). There was a trend toward reduced incidence of upper respiratory illness symptoms in the bovine CPC group (P = 0.055). In summary, low-dose bovine CPC supplementation modulates immune parameters during normal training and after an acute period of intense exercise, which may have contributed to the trend toward reduced upper respiratory illness in the bovine CPC group.

Original languageEnglish
Pages (from-to)1113-1122
Number of pages10
JournalJournal of Applied Physiology
Volume102
Issue number3
DOIs
Publication statusPublished - 2007 Mar

Fingerprint

Colostrum
Proteins
Placebos
Tumor Necrosis Factor Receptors
Serum
Saliva
Immunoglobulin G

Keywords

  • CD38
  • Immunoglobulin
  • Tumor necrosis factor receptor 1

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. / Shing, Cecilia M.; Peake, Jonathan; Suzuki, Katsuhiko; Okutsu, Mitsuharu; Pereira, Rosie; Stevenson, Lesley; Jenkins, David G.; Coombes, Jeff S.

In: Journal of Applied Physiology, Vol. 102, No. 3, 03.2007, p. 1113-1122.

Research output: Contribution to journalArticle

Shing, CM, Peake, J, Suzuki, K, Okutsu, M, Pereira, R, Stevenson, L, Jenkins, DG & Coombes, JS 2007, 'Effects of bovine colostrum supplementation on immune variables in highly trained cyclists', Journal of Applied Physiology, vol. 102, no. 3, pp. 1113-1122. https://doi.org/10.1152/japplphysiol.00553.2006
Shing, Cecilia M. ; Peake, Jonathan ; Suzuki, Katsuhiko ; Okutsu, Mitsuharu ; Pereira, Rosie ; Stevenson, Lesley ; Jenkins, David G. ; Coombes, Jeff S. / Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. In: Journal of Applied Physiology. 2007 ; Vol. 102, No. 3. pp. 1113-1122.
@article{727d0e4d41dd4e3cb1b1568824cff2cd,
title = "Effects of bovine colostrum supplementation on immune variables in highly trained cyclists",
abstract = "The aim of this study was to investigate the influence of low-dose bovine colostrum protein concentrate (CPC) supplementation on selected immune variables in cyclists. Twenty-nine highly trained male road cyclists completed an initial 40-km time trial (TT40) and were then randomly assigned to either a supplement (n = 14, 10 g bovine CPC/day) or placebo group (n = 15, 10 g whey protein concentrate/day). After 5 wk of supplementation, the cyclists completed a second TT40. They then completed 5 consecutive days of high-intensity training (HIT) that included a TT40, followed by a final TT40 in the following week. Venous blood and saliva samples were collected immediately before and after each TT40, and upper respiratory illness symptoms were recorded over the experimental period. Compared with the placebo group, bovine CPC supplementation significantly increased preexercise serum soluble TNF receptor 1 during the HIT period (bovine CPC = 882 ± 233 pg/ml, placebo = 468 ± 139 pg/ml; P = 0.039). Supplementation also suppressed the postexercise decrease in cytotoxic/suppressor T cells during the HIT period (bovine CPC = -1.0 ± 2.7{\%}, placebo = -9.2 ± 2.8{\%}; P = 0.017) and during the following week (bovine CPC = 1.4 ± 2.9{\%}, placebo = -8.2 ± 2.8{\%}; P = 0.004). Bovine CPC supplementation prevented a postexercise decrease in serum IgG 2 concentration at the end of the HIT period (bovine CPC = 4.8 ± 6.8{\%}, P = 0.88; placebo = -9.7 ± 6.9{\%}, P = 0.013). There was a trend toward reduced incidence of upper respiratory illness symptoms in the bovine CPC group (P = 0.055). In summary, low-dose bovine CPC supplementation modulates immune parameters during normal training and after an acute period of intense exercise, which may have contributed to the trend toward reduced upper respiratory illness in the bovine CPC group.",
keywords = "CD38, Immunoglobulin, Tumor necrosis factor receptor 1",
author = "Shing, {Cecilia M.} and Jonathan Peake and Katsuhiko Suzuki and Mitsuharu Okutsu and Rosie Pereira and Lesley Stevenson and Jenkins, {David G.} and Coombes, {Jeff S.}",
year = "2007",
month = "3",
doi = "10.1152/japplphysiol.00553.2006",
language = "English",
volume = "102",
pages = "1113--1122",
journal = "Journal of Applied Physiology Respiratory Environmental and Exercise Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Effects of bovine colostrum supplementation on immune variables in highly trained cyclists

AU - Shing, Cecilia M.

AU - Peake, Jonathan

AU - Suzuki, Katsuhiko

AU - Okutsu, Mitsuharu

AU - Pereira, Rosie

AU - Stevenson, Lesley

AU - Jenkins, David G.

AU - Coombes, Jeff S.

PY - 2007/3

Y1 - 2007/3

N2 - The aim of this study was to investigate the influence of low-dose bovine colostrum protein concentrate (CPC) supplementation on selected immune variables in cyclists. Twenty-nine highly trained male road cyclists completed an initial 40-km time trial (TT40) and were then randomly assigned to either a supplement (n = 14, 10 g bovine CPC/day) or placebo group (n = 15, 10 g whey protein concentrate/day). After 5 wk of supplementation, the cyclists completed a second TT40. They then completed 5 consecutive days of high-intensity training (HIT) that included a TT40, followed by a final TT40 in the following week. Venous blood and saliva samples were collected immediately before and after each TT40, and upper respiratory illness symptoms were recorded over the experimental period. Compared with the placebo group, bovine CPC supplementation significantly increased preexercise serum soluble TNF receptor 1 during the HIT period (bovine CPC = 882 ± 233 pg/ml, placebo = 468 ± 139 pg/ml; P = 0.039). Supplementation also suppressed the postexercise decrease in cytotoxic/suppressor T cells during the HIT period (bovine CPC = -1.0 ± 2.7%, placebo = -9.2 ± 2.8%; P = 0.017) and during the following week (bovine CPC = 1.4 ± 2.9%, placebo = -8.2 ± 2.8%; P = 0.004). Bovine CPC supplementation prevented a postexercise decrease in serum IgG 2 concentration at the end of the HIT period (bovine CPC = 4.8 ± 6.8%, P = 0.88; placebo = -9.7 ± 6.9%, P = 0.013). There was a trend toward reduced incidence of upper respiratory illness symptoms in the bovine CPC group (P = 0.055). In summary, low-dose bovine CPC supplementation modulates immune parameters during normal training and after an acute period of intense exercise, which may have contributed to the trend toward reduced upper respiratory illness in the bovine CPC group.

AB - The aim of this study was to investigate the influence of low-dose bovine colostrum protein concentrate (CPC) supplementation on selected immune variables in cyclists. Twenty-nine highly trained male road cyclists completed an initial 40-km time trial (TT40) and were then randomly assigned to either a supplement (n = 14, 10 g bovine CPC/day) or placebo group (n = 15, 10 g whey protein concentrate/day). After 5 wk of supplementation, the cyclists completed a second TT40. They then completed 5 consecutive days of high-intensity training (HIT) that included a TT40, followed by a final TT40 in the following week. Venous blood and saliva samples were collected immediately before and after each TT40, and upper respiratory illness symptoms were recorded over the experimental period. Compared with the placebo group, bovine CPC supplementation significantly increased preexercise serum soluble TNF receptor 1 during the HIT period (bovine CPC = 882 ± 233 pg/ml, placebo = 468 ± 139 pg/ml; P = 0.039). Supplementation also suppressed the postexercise decrease in cytotoxic/suppressor T cells during the HIT period (bovine CPC = -1.0 ± 2.7%, placebo = -9.2 ± 2.8%; P = 0.017) and during the following week (bovine CPC = 1.4 ± 2.9%, placebo = -8.2 ± 2.8%; P = 0.004). Bovine CPC supplementation prevented a postexercise decrease in serum IgG 2 concentration at the end of the HIT period (bovine CPC = 4.8 ± 6.8%, P = 0.88; placebo = -9.7 ± 6.9%, P = 0.013). There was a trend toward reduced incidence of upper respiratory illness symptoms in the bovine CPC group (P = 0.055). In summary, low-dose bovine CPC supplementation modulates immune parameters during normal training and after an acute period of intense exercise, which may have contributed to the trend toward reduced upper respiratory illness in the bovine CPC group.

KW - CD38

KW - Immunoglobulin

KW - Tumor necrosis factor receptor 1

UR - http://www.scopus.com/inward/record.url?scp=33847725139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847725139&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.00553.2006

DO - 10.1152/japplphysiol.00553.2006

M3 - Article

C2 - 17095643

AN - SCOPUS:33847725139

VL - 102

SP - 1113

EP - 1122

JO - Journal of Applied Physiology Respiratory Environmental and Exercise Physiology

JF - Journal of Applied Physiology Respiratory Environmental and Exercise Physiology

SN - 8750-7587

IS - 3

ER -